Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multi-Center Study to Evaluate the Safety of the Co-administration of Solifenacin Succinate With 0.4 mg Tamsulosin Hydrochloride OCAS (TOCAS) Using Urodynamics in Male Subjects With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)
Brief Summary: A study to evaluate the safety of the co-administration of solifenacin succinate with tamsulosin hydrochloride in men with lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO).


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo to solifenacin, Drug: Placebo to tamsulosin | Arm Label: 6 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Arm Label: 9 mg Solifenacin + 0.4 mg Tamsulosin; Type: EXPERIMENTAL; Interventions: Drug: solifenacin succinate, Drug: tamsulosin hydrochloride | Intervention Type: DRUG; Name: solifenacin succinate; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: tamsulosin hydrochloride; Assigned to Arm(s): 6 mg Solifenacin + 0.4 mg Tamsulosin, 9 mg Solifenacin + 0.4 mg Tamsulosin | Intervention Type: DRUG; Name: Placebo to solifenacin; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: Placebo to tamsulosin; Assigned to Arm(s): Placebo
B: Intervention Type: DRUG; Name: Detrol LA; Assigned to Arm(s): N/A
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg | Arm Label: TOCAS 0.4 mg; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride OCAS 0.4 mg | Arm Label: FDC 0.4 mg/6 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg) | Arm Label: FDC 0.4 mg/9 mg; Type: EXPERIMENTAL; Interventions: Drug: Placebo tamsulosin hydrochloride OCAS 0.4 mg, Drug: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg, Drug: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg) | Intervention Type: DRUG; Name: Placebo tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, FDC 0.4 mg/9 mg, Placebo | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/6 mg; Assigned to Arm(s): FDC 0.4 mg/9 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: Placebo FDC tamsulosin hydrochloride/solifenacin succinate 0.4 mg/9 mg; Assigned to Arm(s): FDC 0.4 mg/6 mg, Placebo, TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride OCAS 0.4 mg; Assigned to Arm(s): TOCAS 0.4 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/6 mg); Assigned to Arm(s): FDC 0.4 mg/6 mg | Intervention Type: DRUG; Name: tamsulosin hydrochloride/solifenacin succinate fixed dose combination (0.4 mg/9 mg); Assigned to Arm(s): FDC 0.4 mg/9 mg
D: Intervention Type: DRUG; Name: Tolterodine ER 4 mg QD; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: Tamsulosin 0.4 mg QD; Assigned to Arm(s): N/A

Answer: A